September 29, 2016 5:15 AM ET

Pharmaceuticals

Company Overview of Javelin Pharmaceuticals, Inc.

Executive Profile

Daniel B. Carr M.D.

President, Chief Medical Officer, and Vice Chairman, Javelin Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 4 Board Members in 4 different organizations across 2 different industries.

See Board Relationships
67--

Background

Dr. Daniel B. Carr, M.D. serves as President, Chief Medical Officer, and Vice Chairman at Javelin Pharmaceuticals, Inc. Dr. Carr serves as a Member of Scientific Advisory Board of Cognetix, Inc., Ascent Private Equity, LLC and Ascent Medical Technology Funds. He is also a Director of Intrac Inc. In March 2003, he was awarded the American Pain Society’s most prestigious honor, the Wilbert E. Fordyce Clinical Investigator Award, for his internationally recognized and widely ...

Corporate Headquarters

125 CambridgePark Drive
Cambridge, Massachusetts 02140

United States

Phone: 617-349-4500
Fax: 617-349-4505

Board Members Memberships

2004-Present
President, Chief Medical Officer, and Vice Chairman

Education

MS
Columbia University
BS
Columbia University
Bachelor's Degree
Columbia College
MD
Edward S. Harkness Eye Institute

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Javelin Pharmaceuticals, Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.